Completed
IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG
NCT01033617
- Conditions
- Cardiovascular Diseases, Heart Diseases, Heart Failure, +9 more
- Locations
-
- Centre de recherche du CHUM (CRCHUM) Montreal, Quebec, Canada